PAD4-IN-2

PAD4-IN-2 Suppliers list

Company Name:	TargetMol Chemicals Inc.
Tel:	+17819995354
Email:	marketing@targetmol.com
Products Intro:	Product Name:PAD4-IN-2 CAS:2642327-52-2 Package:100mg;2500USD\|25mg;1520USD\|50mg;1980USD

Company Name:	TargetMol Chemicals Inc.
Tel:	15002134094
Email:	marketing@targetmol.cn
Products Intro:	Product Name:PAD4-IN-2 CAS:2642327-52-2 Package:100mg/RMB 17500;25mg/RMB 10600;50mg/RMB 13800

PAD4-IN-2 manufacturers

PAD4-IN-2 Basic information

Product Name:	PAD4-IN-2
Synonyms:	PAD4-IN-2;Boronic acid, B-[3-[[[(2S)-5-[(2-chloro-1-iminoethyl)amino]-2-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]-1-oxopentyl]amino]methyl]phenyl]-
CAS:	2642327-52-2
MF:	C20H23BClN7O6
MW:	503.7
EINECS:
Product Categories:
Mol File:	2642327-52-2.mol

PAD4-IN-2 Chemical Properties

density	1.541±0.14 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted)
pka	8.307±0.10(predicted)

Safety Information

MSDS Information

PAD4-IN-2 Usage And Synthesis

Uses	PAD4-IN-2 (compound 5i) is a PAD4 inhibitor (IC50=1.94 μM). PAD4-IN-2 inhibits tumor growth in mice by specifically inhibiting the PAD4-H3cit-NETs pathway in neutrophils[1].
References	[1] Zhu D, et al. Highly-tumor-targeted PAD4 inhibitors with PBA modification inhibit tumors in vivo by specifically inhibiting the PAD4-H3cit-NETs pathway in neutrophils. Eur J Med Chem. 2023 Oct 5;258:115619. DOI:10.1016/j.ejmech.2023.115619

PAD4-IN-2 Preparation Products And Raw materials

Tag:PAD4-IN-2(2642327-52-2) Related Product Information

HomePage | Member Companies | Advertising | Contact us | Previous WebSite | MSDS | CAS Index | CAS DataBase | Privacy | Terms | About Us
All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.